Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. IPCA LABS MARKSANS PHARMA./
IPCA LABS
 
P/E (TTM) x 21.5 51.7 41.5% View Chart
P/BV x 3.9 5.4 73.2% View Chart
Dividend Yield % 0.3 0.3 102.1%  

Financials

 MARKSANS PHARMA.   IPCA LABS
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
IPCA LABS
Mar-23
MARKSANS PHARMA./
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs741,062 7.0%   
Low Rs39768 5.0%   
Sales per share (Unadj.) Rs40.9243.0 16.8%  
Earnings per share (Unadj.) Rs5.919.4 30.2%  
Cash flow per share (Unadj.) Rs7.029.7 23.6%  
Dividends per share (Unadj.) Rs0.504.00 12.5%  
Avg Dividend yield %0.90.4 202.2%  
Book value per share (Unadj.) Rs38.5230.3 16.7%  
Shares outstanding (eoy) m453.16253.70 178.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.43.8 36.7%   
Avg P/E ratio x9.747.2 20.5%  
P/CF ratio (eoy) x8.130.8 26.2%  
Price / Book Value ratio x1.54.0 37.0%  
Dividend payout %8.520.6 41.4%   
Avg Mkt Cap Rs m25,631232,120 11.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2,39412,876 18.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m18,52161,642 30.0%  
Other income Rs m5931,518 39.1%   
Total revenues Rs m19,11563,160 30.3%   
Gross profit Rs m3,3939,033 37.6%  
Depreciation Rs m5192,616 19.8%   
Interest Rs m91482 18.9%   
Profit before tax Rs m3,3777,453 45.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7232,534 28.5%   
Profit after tax Rs m2,6534,919 53.9%  
Gross profit margin %18.314.7 125.0%  
Effective tax rate %21.434.0 63.0%   
Net profit margin %14.38.0 179.5%  
BALANCE SHEET DATA
Current assets Rs m16,99751,893 32.8%   
Current liabilities Rs m3,65418,058 20.2%   
Net working cap to sales %72.054.9 131.3%  
Current ratio x4.72.9 161.9%  
Inventory Days Days651 11.1%  
Debtors Days Days826 1,402.7%  
Net fixed assets Rs m5,24634,336 15.3%   
Share capital Rs m453254 178.6%   
"Free" reserves Rs m16,99858,167 29.2%   
Net worth Rs m17,45258,420 29.9%   
Long term debt Rs m06,518 0.0%   
Total assets Rs m22,24286,229 25.8%  
Interest coverage x38.016.5 230.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.7 116.5%   
Return on assets %12.36.3 197.0%  
Return on equity %15.28.4 180.5%  
Return on capital %19.912.2 162.6%  
Exports to sales %042.9 0.0%   
Imports to sales %7.313.3 54.9%   
Exports (fob) Rs mNA26,434 0.0%   
Imports (cif) Rs m1,3488,178 16.5%   
Fx inflow Rs m6,49126,434 24.6%   
Fx outflow Rs m1,3488,178 16.5%   
Net fx Rs m5,14318,257 28.2%   
CASH FLOW
From Operations Rs m2,3748,058 29.5%  
From Investments Rs m-2,592-7,250 35.8%  
From Financial Activity Rs m1,9785,072 39.0%  
Net Cashflow Rs m1,7605,881 29.9%  

Share Holding

Indian Promoters % 43.9 46.3 94.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.3 44.8 45.4%  
FIIs % 15.6 10.3 151.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 56.2 53.7 104.5%  
Shareholders   237,377 82,809 286.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs IPCA Labs

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs IPCA Labs Share Price Performance

Period MARKSANS PHARMA. IPCA Labs S&P BSE HEALTHCARE
1-Day 0.46% 3.35% 1.18%
1-Month -0.72% 4.27% -0.75%
1-Year 109.61% 56.49% 61.82%
3-Year CAGR 45.11% 9.46% 18.16%
5-Year CAGR 43.62% 20.88% 19.79%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the IPCA Labs share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of IPCA Labs the stake stands at 46.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of IPCA Labs.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

IPCA Labs paid Rs 4.0, and its dividend payout ratio stood at 20.6%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of IPCA Labs.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.